MedPath
HSA Approval

Panadol FluMax Caplets

SIN13452P

Panadol FluMax Caplets

Panadol FluMax Caplets

May 9, 2008

GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.
Licence HolderGSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N02BE51

paracetamol, combinations excl. psycholeptics

Manufacturer Information

gsk consumer healthcare singapore pte. ltd.

GlaxoSmithKline Dungarvan Ltd

SmithKline Beecham, S.A (Primary and Secondary Packager)

Active Ingredients

Phenylephrine hydrochloride

5 mg

Phenylephrine

Caffeine

25 mg

Caffeine

Paracetamol

500 mg

Acetaminophen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Panadol FluMax Caplets - HSA Approval | MedPath